Spyre Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
SYRE chart
What traders are saying about $SYRE
Latest postsSpyre Therapeutics, Inc. news
- Spyre Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Spyre Therapeutics stock hits 52-week high at 110.28 USD By Investing.com
Investing.com Canada ·
- Spyre Therapeutics, Inc. (SYRE) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Spyre Therapeutics (SYRE) Stock Trades At A Premium To Book Value
Yahoo Finance ·
- Spyre Therapeutics grants stock options and RSU...
Pluang ·
- Spyre Therapeutics Announces Grants of Inducement Awards
Yahoo Finance ·
- Deutsche Bank Adjusts Spyre Therapeutics PT to $123 From $127, Maintains Buy Rating
www.marketscreener.com ·
- A Quick Look at Today's Ratings for Spyre Therapeutics(SYRE.US), With a Forecast Between $115 to $131
Moomoo ·
- Spyre Therapeutics Faces Ongoing Dilution Risk and Strategic Constraints From Heavy Reliance on External Financing
TipRanks ·
- How Investors May Respond To Spyre Therapeutics Stock After Phase 2 Data And Wider Losses
Simply Wall St ·
- Spyre Therapeutics, Inc. Stock 12‑Month Price Target Raised to $123, Implies 24% Upside
TradingView ·
- Guggenheim maintains Spyre Therapeutics at Buy, raises price target to $135 from $130
TradingView ·
Spyre Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $886,000 | $2.3M |
| Net income | -$155.2M | -$208.0M | -$338.8M | -$83.8M |
| Diluted EPS | – | – | $13.76 | $-24.86 |
| Total assets (year end) | $777.8M | $608.5M | $341.9M | $71.1M |
| Cash and equivalents (year end) | $85.7M | $89.4M | $188.9M | $34.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Spyre Therapeutics, Inc.
- Ticker
- SYRE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1636282
- Former names
- Aeglea BioTherapeutics, Inc.
Frequently asked questions
What exchange is Spyre Therapeutics, Inc. listed on?
Spyre Therapeutics, Inc. trades on the Nasdaq under the ticker symbol SYRE.
What industry is Spyre Therapeutics, Inc. in?
Spyre Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Spyre Therapeutics, Inc. headquartered?
Spyre Therapeutics, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Spyre Therapeutics, Inc.'s fiscal year end?
Spyre Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Spyre Therapeutics, Inc. report?
Spyre Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.